US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

54.27

-0.6800-1.24%

Volume:1.19M

Turnover:64.54M

Market Cap:132.86B

PE:19.91

High:55.13

Open:55.04

Low:53.94

Close:54.95

Loading ...

Overview Company News Filings

Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program

MT Newswires Live

Nurix Therapeutics in Expanded Collaboration with Sanofi

Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ

Sanofi treatment of immunoglobulin G4-related disease granted orphan status

SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

FDA Approves Sanofi's Hemophilia Drug

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Sanofi Hemophilia Treatment Receives FDA Approval

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

MT Newswires Live

Innate Pharma SA (IPHA) (FY 2024) Earnings Call Highlights: Strategic Advances and Financial ...

Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate

Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag

FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib

Press Release: Availability of the Q1 2025 Aide mémoire

Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals

FedEx downgraded, Adobe upgraded: Wall Street's top analyst calls

Sanofi Initiated at Neutral by Goldman Sachs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNY/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"Sanofi SA","latestPrice":54.27,"timestamp":1746128460969,"preClose":54.95,"halted":0,"volume":1186211,"delay":0,"floatShares":2205948514,"shares":2448069980,"eps":2.726027,"marketStatus":"Trading","change":-0.68,"latestTime":"05-01 15:41:08 EDT","open":55.04,"high":55.125,"low":53.94,"amount":64536518.809177995,"amplitude":0.021565,"askPrice":54.28,"askSize":50,"bidPrice":54.26,"bidSize":283,"shortable":3,"etf":0,"ttmEps":2.726027,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":54.95,"dividendRate":0.037535,"preHourTrading":{"tag":"盘前","latestPrice":55,"preClose":54.95,"latestTime":"08:56 EDT","volume":312,"amount":17232.500064,"timestamp":1746104190374},"postHourTrading":{"tag":"盘后","latestPrice":54.95,"preClose":54.95,"latestTime":"19:59 EDT","volume":3237,"amount":177735.585,"timestamp":1746057553596},"volumeRatio":0.402605,"impliedVol":0.281,"impliedVolPercentile":0.548},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNY\",,,,,undefined,":{"symbol":"SNY","floatShares":2205948514,"roa":"4.28%","roe":"7.30%","lyrEps":2.29994,"volumeRatio":0.402605,"shares":2448069980,"dividePrice":2.037,"high":55.125,"amplitude":0.021565,"preClose":54.95,"low":53.94,"week52Low":45.8,"pbRate":"1.52","psRate":"2.61","week52High":60.115,"institutionHeld":0.0837,"latestPrice":54.27,"committee":0.6997,"eps":2.726027,"divideRate":0.037535,"volume":1186211,"delay":0,"ttmEps":2.726027,"open":55.04,"prevYearClose":48.23,"prevWeekClose":52.32,"prevMonthClose":54.95,"prevQuarterClose":55.46,"fiveDayClose":53.54,"twentyDayClose":53.95,"sixtyDayClose":53.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNY\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524464194","title":"Nurix Therapeutics Signs Exclusive Licensing Deal With Sanofi for Autoimmune Disease Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2524464194","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524464194?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:46","pubTimestamp":1743594368,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics  said Wednesday that Sanofi  has exclusively licensed an undisclosed Nurix program targeting a previously undruggable transcription factor for autoimmune diseases.The company said the target is a key regulator of inflammation and is separate from its earlier disclosed STAT6 degrader program.Under the collaboration, Nurix said it will use its DEL-AI drug discovery platform to identify new agents that utilize E3 ligases to degrade the target.Sanofi has the right to license drug candidates resulting from the work, while Nurix has the option to co-develop and co-promote up to two products in the US after clinical proof of concept, it added.For programs where Nurix doesn't exercise its co-development option, it will receive milestones and royalties based on global sales, the company said.Nurix said it received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount to date to $105 million, and is eligible for up to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SNY","BK4588","IE00BFXG1179.USD","BK4007","NRIX","BK4585","SNYNF"],"gpt_icon":0},{"id":"2524461423","title":"Nurix Therapeutics in Expanded Collaboration with Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2524461423","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524461423?lang=en_us&edition=fundamental","pubTime":"2025-04-02 19:33","pubTimestamp":1743593580,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics has widened its collaboration with Sanofi, granting the French pharmaceutical company an exclusive license to an undisclosed program targeting a previously undruggable transcription factor for autoimmune diseases.Nurix on Wednesday said it received a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the total amount the San Francisco clinical-stage biopharmaceutical company has received to date under the pact to $105 million.Nurix said the new collaboration target is a central regulator of the inflammation response and is distinct from the companies' existing STAT6 degrader program.Nurix said it remains eligible for up to $465 million in development, regulatory and commercial milestone payments per licensed program under its work with Sanofi, as well as royalties on future sales.Shares of Nurix were recently up 3.1% to $10.79 in premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","BK4007","BK4139","IE00BFXG1179.USD","NRIX","BK4585","SNYNF","BK4588"],"gpt_icon":0},{"id":"2524451039","title":"Stocks to Watch Wednesday: Tesla, Newsmax, Novo Nordisk -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2524451039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524451039?lang=en_us&edition=fundamental","pubTime":"2025-04-02 17:27","pubTimestamp":1743586020,"startTime":"0","endTime":"0","summary":"Tesla : The e-vehicle maker's quarterly delivery figures are expected early Wednesday. Shares shed about 1% ahead of the open. The stock has slid this year amid a consumer backlash to Elon Musk's political activities, and tariff uncertainty.Auto stocks: In Germany, shares of automotive supplier Continental  and BMW  both declined. In Asia, Hyundai  lost 1.2%. Ford , General Motors  and Jeep maker Stellantis  were little changed in U.S. premarket trading.Global pharma stocks: Danish Ozempic maker Novo Nordisk  fell more than 2%. Also under pressure: Germany's Bayer , France's Sanofi  and the U.K.'s GSK . Most U.S. drug makers were little changed ahead of the bell.Newsmax : Shares slid more than 30% premarket, continuing a rollercoaster first week of trading for the conservative TV outlet.Grifols : Private-equity firm Brookfield Asset Management  has reopened takeover talks with Grifols. The pharmaceutical company's shares jumped 14% in Madrid midday trading.This item is part of a Wall S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0648001328.SGD","LU1064927863.SGD","LU1720051108.HKD","LU0648000940.SGD","LU0154236417.USD","LU0345769631.USD","LU1839511570.USD","LU1861220033.SGD","LU1066051225.USD","TSYW.SI","LU0345770308.USD","BK4007","LU0820561909.HKD","BAYRY","BK4566","LU1201861165.SGD","TSLA","GM","SNY","LU1066053197.SGD","BK4527","LU2108987350.USD","F","GSK.UK","LU1914381329.SGD","TSLL","LU0234570918.USD","NVO","CTTAY","BK4550","LU2750360641.GBP","LU2756315664.SGD","LU1551013342.USD","LU2357305700.SGD","GRFS","BK4598","SG9999015945.SGD","BK4574","STLA","LU1548497426.USD","LU0820562030.AUD","LU0211331839.USD","NMAX","BK4612","SG9999015978.USD","GSK","BK4533","BK4561","LU1093756325.SGD"],"gpt_icon":1},{"id":"2524142638","title":"Sanofi treatment of immunoglobulin G4-related disease granted orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2524142638","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524142638?lang=en_us&edition=fundamental","pubTime":"2025-04-02 00:35","pubTimestamp":1743525312,"startTime":"0","endTime":"0","summary":"The FDA granted Sanofi (SNY) US Services’ rilzabrutinib orphan designation as a treatment of immunoglobulin G4-related disease, according to a post...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sanofi-treatment-of-immunoglobulin-g4-related-disease-granted-orphan-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sanofi-treatment-of-immunoglobulin-g4-related-disease-granted-orphan-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF","SNY","BK4585","BK4588","IE00BFXG1179.USD","BK4007"],"gpt_icon":0},{"id":"2524145956","title":"SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2524145956","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524145956?lang=en_us&edition=fundamental","pubTime":"2025-04-01 21:44","pubTimestamp":1743515040,"startTime":"0","endTime":"0","summary":"SanofiSNY and partner,Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia  as the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors in the United States.Hemophilia A and B are rare, lifelong congenital bleeding disorders that impair the blood's ability to clot, causing excessive bleeding and spontaneous joint bleeds. These can lead to joint damage, chronic pain, which takes a significant toll on the patients’ quality of life.This FDA approval is based on positive data from the phase III ATLAS studies of Qfitlia, which showed clinically significant bleed protection, as measured by annualized bleeding rates , in hemophilia patients with or without inhibitors.Year to date, SNY stock has gained 15% compared with the industry’s 3.4% growth.Further analysis in the open-label extension study, under the ATL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sny-gets-fda-nod-first-134400996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UBCP","SNY","ABR","BK4139","LU1559883803.SGD","BAYRY","CORT","BK4110","BK4548","BK4585","BK4588","IE00BFXG1179.USD","LU0566484027.USD","ALNY","BK4007","BK4211","BK4532"],"gpt_icon":0},{"id":"1185252208","title":"Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1185252208","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185252208?lang=en_us&edition=fundamental","pubTime":"2025-03-31 21:38","pubTimestamp":1743428305,"startTime":"0","endTime":"0","summary":"Moderna Shares Down 14% Premarket After Report Top Vaccine Official Peter Marks Forced Out at FDA","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Moderna Shares Tumble After Report Top Vaccine Official Peter Marks Forced Out at FDA","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","SNY","GSK","OCGN","NVAX","VXRT","LLY","IBIO","MRK","VERU","REGN","ABT","VIR","JNJ","BNTX","GILD","AZN","MRNA"],"gpt_icon":1},{"id":"2523949132","title":"FDA Approves Sanofi's Hemophilia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949132","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949132?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:28","pubTimestamp":1743424092,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration on Friday approved Sanofi SA’s  Qfitlia , the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors.The approval is based on data from the ATLAS phase 3 studies that demonstrated clinically meaningful bleed protection as measured by annualized bleeding rates .Also Read: Sanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal. By lowering AT, a protein that inhibits blood clotting, Qfitlia helps increase thrombin generation to restore hemostasis in hemophilia patients.In the ATLAS clinical development program, Qfitlia demonstrated low bleed rates across subgroups with as few as six injections a year. Key results include:. Significant bleed reduction by 71% in ABR for patients without inhibitors treated with Qfitlia prophylaxis compared to clotting factor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-approves-sanofis-hemophilia-drug-122812095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4110","BK4007","ALNY","IE00BFXG1179.USD","SNY","BK4139","BK4588","BK4548","ABR","SNYNF","BK4585"],"gpt_icon":0},{"id":"2523639953","title":"Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2523639953","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523639953?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:07","pubTimestamp":1743192420,"startTime":"0","endTime":"0","summary":"Qfitlia , the first antithrombin-lowering therapy in hemophilia, offers consistent protection with as few as six injections a year via a prefilled pen or vial and syringe. Unique mechanism helps reduce the frequency of bleeding episodes for people with hemophilia. Paris, March 28, 2025. The US Food and Drug Administration  has approved Qfitlia , the first antithrombin-lowering  therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients  with hemophilia A or B with or without factor VIII or IX inhibitors. The approval is based on data from the ATLAS phase 3 studies that demonstrated clinically meaningful bleed protection as measured by annualized bleeding rates  across hemophilia patients with or without inhibitors.Significant bleed reduction by 71% in ABR for patients without inhibitors treated with Qfitlia prophylaxis compared to clotting factor concen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-qfitlia-approved-first-200700830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG1179.USD","BK4585","ABR","BK4110","BK4588","SNY","BK4007"],"gpt_icon":0},{"id":"2523416687","title":"Sanofi Hemophilia Treatment Receives FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2523416687","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523416687?lang=en_us&edition=fundamental","pubTime":"2025-03-29 03:54","pubTimestamp":1743191643,"startTime":"0","endTime":"0","summary":"Sanofi  received the US Food and Drug Administration approval for Qfitlia used to prevent bleeding in patients aged at least 12 with hemophilia A or B, according to a statement by the FDA Friday.Qfitlia reduces antithrombin levels to improve blood clotting instead of replacing missing clotting factors, according to the statement.The medicine is administered subcutaneously, initially once every two months, and the dosage is adjusted using the FDA-approved Innovance Antithrombin test, the FDA said in its statement. The fixed dose of Qfitlia is not FDA approved because it led to excessive clotting in some patients.Qfitlia's safety and effectiveness were confirmed in two studies involving 177 male patients, comparing its use to traditional on-demand treatments, the statement added. Qfitlia reduced bleeding rates by 73% in patients with inhibitors and 71% in those without inhibitors compared to standard treatments.Qfitlia carries serious warnings about blood clot risks, gallbladder disease,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4007","BK4588","SNY","SNYNF","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2522250119","title":"European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2522250119","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522250119?lang=en_us&edition=fundamental","pubTime":"2025-03-28 23:09","pubTimestamp":1743174595,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.49% to 1,404.43 on the S&P Europe Select ADR Index, which is about 1.5% lower for the week.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Genfit , which advanced 49% and 5.2% respectively. They were followed by pharmaceutical company Sanofi , which rose 1.5%.The decliners from continental Europe were led by internet advertising firm Criteo , which fell 3.6%. It was followed by internet browser company Opera  and financial services company Banco Bilbao Vizcaya Argentaria , which were down 3.1% and 2.8% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company NuCana  and utilities provider National Grid , which increased 5.6% and 2.9% respectively. They were followed by telecommunications operator Vodafone Group  and biopharmaceutical company Adaptimmune Therapeutics , which were up 2% and 1.6% re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPRA","BK4142","IE00BFMHRM44.USD","BK4505","BK4139","BK4585","BK4588","BK4521","IE00BFXG1179.USD","AMRN","DBVT","BK4009","AFG","ADAP","BBVA","NGG","BCS","BK4117","BK4132","CRTO","VOD","BK4023","BK4208","GNFT","BK4007","SNY","NCNA","BK4107","MREO","CUK","BK4207","BK4532"],"gpt_icon":0},{"id":"2522519428","title":"Innate Pharma SA (IPHA) (FY 2024) Earnings Call Highlights: Strategic Advances and Financial ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2522519428","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522519428?lang=en_us&edition=fundamental","pubTime":"2025-03-28 15:01","pubTimestamp":1743145305,"startTime":"0","endTime":"0","summary":"Revenue and Other Income: 20.1 million in 2024, primarily from collaboration licensing agreements  and a research tax credit .Operating Expenses: 71.7 million in 2024, with 73% related to R&D.General and Administrative Expenses: 19.7 million in 2024, an increase of 1.4 million from the previous year.R&D Expenses: 52 million in 2024, a reduction of 4 million from the prior year.Cash and Financial Assets: 91.1 million as of December 31, 2024.Financial Liabilities: 31 million, down from 39.9 million at the end of 2023.GuruFocus has detected 6 Warning Signs with IPHA.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Innate Pharma SA  successfully recruited the first patients into the phase 1 dose-finding trial for IPH 65, marking a critical step in its clinical development.Q: What are Innate Pharma's expectations for IPH 6,501 in the non-Hodgkin lymphoma  market, considering the underperformance of recent CD-19 targeted therapies?Q: Is Sano","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innate-pharma-sa-ipha-fy-070145850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SNY","IPHA"],"gpt_icon":0},{"id":"2522518458","title":"Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD","url":"https://stock-news.laohu8.com/highlight/detail?id=2522518458","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522518458?lang=en_us&edition=fundamental","pubTime":"2025-03-28 14:00","pubTimestamp":1743141600,"startTime":"0","endTime":"0","summary":"Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adults with elevated eosinophils. Approval marks the first new treatment approach for COPD in more than a decade in Japan and the sixth approved indication for chronic diseases with underlying type 2 inflammation. Paris and Tarrytown, NY, March 28, 2025. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent  for the treatment of chronic obstructive pulmonary disease  in adults whose disease is not adequately controlled with existing therapy.About Sanofi and Regeneron’s COPD clinical research programSanofi and Regeneron are motivated to transform the treatment paradigm of COPD by examining the role different types of inflammation","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-dupixent-approved-first-060000979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG1179.USD","LU1974910355.USD","SNY","LU1917777945.USD","BK4585","LU2362541273.HKD","LU0109394709.USD","LU2089984988.USD","LU2362541513.USD","LU2468319806.SGD","BK4139","BK4588","BK4007","REGN","LU0053666078.USD","LU0320765992.SGD","LU2237438978.USD","LU0882574055.USD","LU0114720955.EUR","LU0823416689.USD","LU0289739699.SGD","LU2023250504.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0889565916.HKD","LU0058720904.USD"],"gpt_icon":0},{"id":"2522051811","title":"Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522051811","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522051811?lang=en_us&edition=fundamental","pubTime":"2025-03-28 14:00","pubTimestamp":1743141600,"startTime":"0","endTime":"0","summary":"Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for COP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/28/3051139/0/en/Dupixent-dupilumab-Approved-as-the-First-ever-Biologic-Medicine-in-Japan-for-Patients-with-Chronic-Obstructive-Pulmonary-Disease-COPD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4156","LU0058720904.USD","LU2023250504.SGD","LU2089984988.USD","LU2362541513.USD","PN","LU2237438978.USD","BK4139","LU0114720955.EUR","SNY","BK4007","BK4588","LU0320765992.SGD","REGN","BK4585","LU2362540622.SGD","LU0823416689.USD","LU0109394709.USD","BK4096","LU2362541273.HKD","LU0289739699.SGD","IE00BFXG1179.USD","LU0882574055.USD","LU1917777945.USD","LU2468319806.SGD","LU1974910355.USD","LU0889565916.HKD","LU0053666078.USD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2522634107","title":"Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522634107","media":"Fortune","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522634107?lang=en_us&edition=fundamental","pubTime":"2025-03-27 14:00","pubTimestamp":1743055200,"startTime":"0","endTime":"0","summary":"Sanofi has managed the daunting task faced by managers worldwide: hauling its employees back to the office with minimal fuss.That’s an impressive feat for a company that said last year it was going “all-in on AI.” The $50 billion French pharmaceutical giant Sanofi is quickly converting its operations to an AI-first model. Thousands of employees utilize its automated app Plai, powered by German startup Aily Labs, on a daily basis.Managers at the company are able to pinpoint manufacturing capacity at plants across the world and quickly schedule meetings with colleagues using its AI agents, cutting communication barriers in Sanofi’s multinational operations.However, despite all this global digitization, the company has reinforced the need for face-to-face contact to drive innovation.Sanofi employees work in the office three days a week under a hybrid model, typically coming in on Tuesdays, Wednesdays, and Thursdays.Others, however, including Amazon and iPhone challenger Nothing, have aske","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofi-chief-digital-officer-says-060000605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","SNYNF","SNY","BK4007","IE00BFXG1179.USD","BK4588"],"gpt_icon":0},{"id":"2522056336","title":"Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2522056336","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522056336?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:53","pubTimestamp":1743004380,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of chlamydia infection.The company plans to begin a phase I/II study soon, which will evaluate the immunogenicity and safety of the vaccine candidate in adults aged between 18 and 29 years.Sanofi decided to begin the phase I/II study after the chlamydia vaccine candidate demonstrated promising results in pre-clinical studies.Caused by the bacteriumChlamydia trachomatis,chlamydia is a common bacterial infection of the reproductive tract that can lead to infertility and pregnancy complications.The vaccine candidate is being developed to protect against primary genital tract infection and reinfection by the bacterium.In the past 60 days, estimates for Krystal Biotech’s earnings per share have increased from $5.50 to $7.06 for 2025. During the same time, earnings per share estimates for 2026 have increased from $9.15 to $11. Year to date, shares of KRYS have rallied 22.8%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofis-chlamydia-vaccine-candidate-gets-155300129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FAST","BK4104","LU0889565916.HKD","IE00BFXG0V08.USD","BK4585","LU1585245621.USD","IE00BYQQ9H92.USD","LU1571399168.USD","IE00B19Z3B42.SGD","IE00BFXG1179.USD","BK4566","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4588","BK4532","LU2468319806.SGD","IE00B5TLWC47.USD","LU1430594728.SGD","LU2089984988.USD","LU1839511570.USD","LU0109394709.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4568","KRYS","IE0002270589.USD","BK4007","SNY","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","SNYNF","BK4567","BK4583","LU1066053197.SGD","LU0289739699.SGD","GILD","BK4139","BK4578","LU0320765992.SGD","LU1066051498.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2522079582","title":"FDA Accepts Sanofi's Filing for Multiple Sclerosis Drug Tolebrutinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2522079582","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522079582?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:56","pubTimestamp":1742903760,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has accepted its regulatory filing seeking approval for its investigational BTK inhibitor tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis  and slow disability accumulation independent of relapse activity in adults.The filing has been granted priority review by the FDA, bringing down the review period by four months. A final decision is expected by Sept. 28, 2025.The FDA filing is supported by data from three late-stage studies — one  in nrSPMS and two  in relapsing MS . Data from these studies showed that patients treated with tolebrutinib delayed the time to onset of six-month confirmed disability progression when compared to placebo. A similar regulatory filing for the drug is currently under review by the EMA, which is also supported by data from these studies.Per Sanofi, the above results make tolebrutinib the first and the only brain-penetrant BTK inhibitor to treat both the above MS indications. If approved, tolebruti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-accepts-sanofis-filing-multiple-115600487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MG","SNYNF","LU2133065610.SGD","BK4139","LU1363072403.SGD","LU0098860793.USD","LU2357305700.SGD","LU0106831901.USD","LU0225283273.USD","ETNB","BK4504","LU2271345857.HKD","LU0912757837.SGD","IE00BKVL7J92.USD","LU1720051108.HKD","IE0031619046.USD","LU0971096721.USD","LU0314104364.USD","BK4581","SNY","IE00B19Z4B17.USD","BK4516","BK4585","LU0795875169.SGD","LU2028103732.USD","LU0158827948.USD","LU1720051017.SGD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU1732800096.USD","BK4123","LU0106261372.USD","ANIP","LU0158827781.USD","LU1668664300.SGD","BK4534","CTMX","BK4588","LU2023251221.USD","LU2111349929.HKD","LU2089283258.USD","LU1989772840.SGD","LU1162221912.USD","LU0320765646.SGD","IE00BFXG1179.USD","IE00B66KJ199.SGD","LU1732799900.SGD","LU0267386448.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2521796613","title":"Press Release: Availability of the Q1 2025 Aide mémoire","url":"https://stock-news.laohu8.com/highlight/detail?id=2521796613","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521796613?lang=en_us&edition=fundamental","pubTime":"2025-03-24 14:30","pubTimestamp":1742797800,"startTime":"0","endTime":"0","summary":"Paris, France – March 24, 2025. Sanofi announced today that its Q1 2025 Aide mémoire is available on the \"Investors\" page of the company's website:. As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity losses as well as the foreign currency impact and share count. Sanofi's first quarter 2025 results will be published on April 24, 2025.Media RelationsSandrine Guendoul|+ 33 6 25 09 14 25 |sandrine.guendoul@sanofi.comEvan Berland | + 1 215 432 0234 | evan.berland@sanofi.comNicolas Obrist|+ 33 6 77 21 27 55 |nicolas.obrist@sanofi.comLéo Le Bourhis |+ 33 6 75 06 43 81 |leo.lebourhis@sanofi.comVictor Rouault|+ 33 6 70 93 71 40 |victor.rouault@sanofi.com Timothy Gilbert | + 1 516 521 2929 | timothy.gilbert@sanofi.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/press-release-availability-q1-2025-063000225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4007","SNY","BK4585","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2521498258","title":"Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2521498258","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521498258?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:26","pubTimestamp":1742574360,"startTime":"0","endTime":"0","summary":"This week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease  condition, Crohn’s disease , and Novartis’ NVS Fabhalta for its third indication, C3 glomerulopathy . Pfizer PFE sold its remaining 7.3% stake in Haleon, thus fully exiting the consumer health company. Sanofi SNY and AstraZeneca AZN announced small acquisition deals.Here's a recap of the week’s most important stories.Haleon was a consumer health joint venture jointly created by Pfizer and GSK in 2019. GSK owned a controlling stake of 68% in the Consumer Healthcare JV . GSK/Pfizer divested the CHC JV to form Haleon in July 2022. GSK, which initially owned a nearly 13% stake in Haleon, sold its entire stake in May 2024. Pfizer originally held a 32% stake in Haleon, which it had started gradually reducing since 2022.FDA Approves NVS’ Fabhalta for Rare Kidney Disease","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pharma-stock-roundup-pfes-final-162600943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2129689514.USD","LU1829250122.USD","LU1221951046.USD","LU2505996509.AUD","LU0889566641.SGD","LU1221951129.SGD","LU2462157665.USD","LU0109394709.USD","LU2236285917.USD","NVS","LU0225771236.USD","LU1674673691.USD","AZN","LU1267930813.SGD","BK4183","LU1057294990.SGD","LU1066051498.USD","LU1778281490.HKD","LU2592432038.USD","LU2430703178.SGD","SG9999003800.SGD","IE00BLSP4239.USD","LU1506573853.SGD","LU0985481810.HKD","LU0098860793.USD","LU0058720904.USD","JNJ","LU2430703095.HKD","BK4007","LU1280957306.USD","LU2129689605.HKD","PFE","LU0234570918.USD","SNY","SG9999002224.SGD","IE00BFTCPJ56.SGD","LU0225284248.USD","IE00B19Z3B42.SGD","LU0320765646.SGD","SG9999002232.USD","BK4581","BK4532","LU1732800096.USD","IE00BJJMRZ35.SGD","BK4550","LU1585245621.USD","LU0795875169.SGD","BK4592","SG9999011175.SGD","HLN"],"gpt_icon":1},{"id":"2521238811","title":"FedEx downgraded, Adobe upgraded: Wall Street's top analyst calls","url":"https://stock-news.laohu8.com/highlight/detail?id=2521238811","media":"The Fly","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521238811?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:32","pubTimestamp":1742563923,"startTime":"0","endTime":"0","summary":"The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades:. KeyBanc upgraded Adobe  to Sector Weight from Underweight. The firm sees little room for downside as well as revisions to fundamentals through the remainder of the year.JPMorgan upgraded Super Micro  to Neutral from Underweight with a price target of $45, up from $35. The company has cycled past the uncertainty in relation to pending SEC filings and is on the cusp of benefitting from the ramp in Blackwell based server shipments, which are already seeing materially higher demand than prior generation, the firm tells investors.Goldman Sachs upgraded Danaher  to Buy from Neutral with a $260 price target. Since the firm's downgrade at the end of 2023, FY25 consensus estimates have come down 8% for reported revenue growth and 12% for EPS, while \"more importantly,\" consensus organic growth estimate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fedex-downgraded-adobe-upgraded-wall-133203329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADBE","SNY","FDX"],"gpt_icon":1},{"id":"2521774904","title":"Sanofi Initiated at Neutral by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2521774904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521774904?lang=en_us&edition=fundamental","pubTime":"2025-03-21 17:32","pubTimestamp":1742549520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SNY/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 21, 2025 05:32 ET (09:32 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNYNF","SNY"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNY\",params:#limit:5,,,undefined,":[{"date":"2025-05-09","symbol":"SNY","amount":2.212154,"announcedDate":"2025-04-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"赛诺菲安万特","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-12","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-06-12"},{"market":"US","date":"2025-04-24","symbol":"SNY","fiscalQuarterEnding":"2025/03","expectedEps":0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":0.94},{"market":"US","date":"2025-01-30","symbol":"SNY","fiscalQuarterEnding":"2024/12","expectedEps":0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-10-25","symbol":"SNY","fiscalQuarterEnding":"2024/09","expectedEps":1.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1729828800000,"reportTimeType":"pre","actualEps":1.57},{"date":"2024-09-12","symbol":"SNY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1726128000000,"name":null,"time":"Pre-Market","dateTimestamp":1726113600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNY\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-06","recordDate":"2015-05-08","paymentDate":"2015-06-02","value":1.086507,"currency":"USD"},{"executeDate":"2016-05-05","recordDate":"2016-05-09","paymentDate":"2016-06-01","value":1.124297,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":"2017-05-15","paymentDate":"2017-06-07","value":1.053962,"currency":"USD"},{"executeDate":"2018-05-09","recordDate":"2018-05-10","paymentDate":"2018-06-04","value":1.252612,"currency":"USD"},{"executeDate":"2019-05-07","recordDate":"2019-05-08","paymentDate":"2019-05-31","value":1.739462,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.2857,"hold":0.2857,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1742616000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNY","date":"2025-04-30","current":18.635491,"percent":0.621931,"low":7.700371,"twenty":10.042807,"median":17.659092,"eighty":24.062008,"high":35.240461,"avg":17.73217,"sd":6.865548,"marketCap":133180117473.34},"quantilePoints":[{"date":"2020-05-01","current":33.287209,"twenty":10.936939,"median":22.288206,"eighty":27.915788,"marketCap":122748871163.92},{"date":"2020-05-08","current":33.429348,"twenty":10.947749,"median":22.313398,"eighty":28.361828,"marketCap":121627238914.58},{"date":"2020-05-15","current":32.595691,"twenty":10.949613,"median":22.330456,"eighty":28.489712,"marketCap":118247569927.49},{"date":"2020-05-22","current":32.461152,"twenty":10.950809,"median":22.368981,"eighty":28.664689,"marketCap":118529173787.58},{"date":"2020-05-29","current":32.711543,"twenty":10.957417,"median":22.45326,"eighty":28.739014,"marketCap":121900047291.83},{"date":"2020-06-05","current":33.320704,"twenty":10.961705,"median":22.504413,"eighty":28.869762,"marketCap":126404479866.46},{"date":"2020-06-12","current":33.26848,"twenty":10.97427,"median":22.552737,"eighty":29.165734,"marketCap":125312894610.63},{"date":"2020-06-19","current":35.174448,"twenty":10.980961,"median":22.560851,"eighty":29.253683,"marketCap":131987852645.25},{"date":"2020-06-26","current":34.045816,"twenty":10.987268,"median":22.616571,"eighty":29.711727,"marketCap":127924643785.45},{"date":"2020-07-02","current":34.367214,"twenty":10.994274,"median":22.648355,"eighty":29.771242,"marketCap":129509727296.23},{"date":"2020-07-10","current":33.233448,"twenty":10.9995,"median":22.663506,"eighty":32.384166,"marketCap":126030678803.03},{"date":"2020-07-17","current":34.840553,"twenty":11.002375,"median":22.680357,"eighty":32.642032,"marketCap":133469182626.29},{"date":"2020-07-24","current":33.192336,"twenty":11.004309,"median":22.714228,"eighty":32.855777,"marketCap":129403011819.03},{"date":"2020-07-31","current":10.079688,"twenty":10.9995,"median":22.705861,"eighty":32.972702,"marketCap":131609513547.85},{"date":"2020-08-07","current":9.946507,"twenty":10.971294,"median":22.66842,"eighty":32.855777,"marketCap":129396034746.58},{"date":"2020-08-14","current":9.727952,"twenty":10.948867,"median":22.658549,"eighty":32.749663,"marketCap":127031956635.12},{"date":"2020-08-21","current":9.828123,"twenty":10.929747,"median":22.644775,"eighty":32.720989,"marketCap":127780651499.59},{"date":"2020-08-28","current":9.679005,"twenty":10.883242,"median":22.578254,"eighty":32.71485,"marketCap":127069323852.74},{"date":"2020-09-04","current":9.512813,"twenty":10.85502,"median":22.559456,"eighty":32.642032,"marketCap":123841606541.64},{"date":"2020-09-11","current":9.96472,"twenty":10.823199,"median":22.547298,"eighty":32.561309,"marketCap":130185382800.66},{"date":"2020-09-18","current":10.067167,"twenty":10.684765,"median":22.493564,"eighty":32.490302,"marketCap":131820291420.1},{"date":"2020-09-25","current":9.858857,"twenty":10.595525,"median":22.444418,"eighty":32.458162,"marketCap":126422921729.99},{"date":"2020-10-02","current":9.798527,"twenty":10.526117,"median":22.342652,"eighty":32.407337,"marketCap":126679565248.92},{"date":"2020-10-09","current":9.824708,"twenty":10.410161,"median":22.324584,"eighty":32.285505,"marketCap":128128683268.34},{"date":"2020-10-16","current":9.793052,"twenty":10.315413,"median":22.302943,"eighty":31.257628,"marketCap":126623612278.58},{"date":"2020-10-23","current":9.441308,"twenty":10.238589,"median":22.261435,"eighty":29.811136,"marketCap":123347203619.79},{"date":"2020-10-30","current":8.661295,"twenty":10.199611,"median":22.234806,"eighty":29.773341,"marketCap":113280166110.01},{"date":"2020-11-06","current":9.327376,"twenty":10.132097,"median":22.205679,"eighty":29.767042,"marketCap":124442629581.55},{"date":"2020-11-13","current":9.605003,"twenty":10.089923,"median":22.112471,"eighty":29.762798,"marketCap":127479835927.15},{"date":"2020-11-20","current":9.6106,"twenty":10.079688,"median":22.081393,"eighty":29.73408,"marketCap":127917182157.26},{"date":"2020-11-27","current":9.538955,"twenty":10.057978,"median":22.005256,"eighty":29.655002,"marketCap":127995801275.71},{"date":"2020-12-04","current":9.358721,"twenty":10.040076,"median":21.945075,"eighty":29.437865,"marketCap":127467141893.2},{"date":"2020-12-11","current":8.790033,"twenty":10.022546,"median":21.91943,"eighty":29.296005,"marketCap":119489512407.95},{"date":"2020-12-18","current":8.844887,"twenty":9.993694,"median":21.901999,"eighty":29.279125,"marketCap":121396802063.1},{"date":"2020-12-24","current":8.769883,"twenty":9.976103,"median":21.881466,"eighty":29.245202,"marketCap":119941986349.01},{"date":"2020-12-31","current":8.810183,"twenty":9.961936,"median":21.873052,"eighty":29.24273,"marketCap":120950078152.91},{"date":"2021-01-08","current":8.820259,"twenty":9.95106,"median":21.862976,"eighty":29.210969,"marketCap":121221849881.21},{"date":"2021-01-15","current":9.126992,"twenty":9.936588,"median":21.828735,"eighty":29.197581,"marketCap":123845036018.62},{"date":"2021-01-22","current":9.119156,"twenty":9.919292,"median":21.813001,"eighty":29.173346,"marketCap":124582207014},{"date":"2021-01-29","current":8.636715,"twenty":9.906894,"median":21.809329,"eighty":29.059102,"marketCap":117661873131.83},{"date":"2021-02-05","current":8.176599,"twenty":9.88162,"median":21.779975,"eighty":28.982923,"marketCap":120922774999.4},{"date":"2021-02-12","current":7.987538,"twenty":9.856239,"median":21.763827,"eighty":28.950951,"marketCap":119014418424.43},{"date":"2021-02-19","current":7.870014,"twenty":9.848372,"median":21.763595,"eighty":28.901957,"marketCap":117391358460.33},{"date":"2021-02-26","current":7.746359,"twenty":9.840411,"median":21.746147,"eighty":28.832667,"marketCap":115225330598.91},{"date":"2021-03-05","current":7.860937,"twenty":9.827943,"median":21.729717,"eighty":28.787173,"marketCap":115132662522.04},{"date":"2021-03-12","current":8.118972,"twenty":9.808685,"median":21.685029,"eighty":28.757776,"marketCap":119210132761.26},{"date":"2021-03-19","current":8.502978,"twenty":9.798186,"median":21.612115,"eighty":28.742096,"marketCap":124417528040.94},{"date":"2021-03-26","current":8.489771,"twenty":9.792219,"median":21.598158,"eighty":28.727957,"marketCap":123096173961.55},{"date":"2021-04-01","current":8.553964,"twenty":9.788159,"median":21.54258,"eighty":28.711437,"marketCap":123735063715.73},{"date":"2021-04-09","current":8.641332,"twenty":9.782356,"median":21.526019,"eighty":28.694903,"marketCap":126246626546.64},{"date":"2021-04-16","current":8.636253,"twenty":9.769654,"median":21.512492,"eighty":28.66049,"marketCap":127185060180.88},{"date":"2021-04-23","current":8.669778,"twenty":9.761091,"median":21.479045,"eighty":28.625112,"marketCap":128556561372.57},{"date":"2021-04-30","current":8.936356,"twenty":9.755206,"median":21.457669,"eighty":28.539275,"marketCap":131116008424.15},{"date":"2021-05-07","current":8.761308,"twenty":9.751942,"median":21.433287,"eighty":28.492512,"marketCap":129875631253.04},{"date":"2021-05-14","current":8.892563,"twenty":9.741584,"median":21.426198,"eighty":28.475014,"marketCap":131645337996.12},{"date":"2021-05-21","current":9.047404,"twenty":9.729833,"median":21.41999,"eighty":28.415141,"marketCap":134492606805.61},{"date":"2021-05-28","current":9.019717,"twenty":9.710422,"median":21.40835,"eighty":28.40452,"marketCap":134081034734.92},{"date":"2021-06-04","current":8.826935,"twenty":9.707463,"median":21.392314,"eighty":28.379325,"marketCap":130991765454.43},{"date":"2021-06-11","current":9.116284,"twenty":9.694395,"median":21.363939,"eighty":28.361828,"marketCap":134500207706.54},{"date":"2021-06-18","current":9.021943,"twenty":9.679005,"median":21.290156,"eighty":28.230746,"marketCap":130457184786.01},{"date":"2021-06-25","current":9.04963,"twenty":9.672117,"median":21.229467,"eighty":28.073267,"marketCap":131826509965.36},{"date":"2021-07-02","current":9.013739,"twenty":9.660792,"median":21.196129,"eighty":27.996278,"marketCap":130199639608.01},{"date":"2021-07-09","current":8.944008,"twenty":9.658829,"median":21.16444,"eighty":27.931886,"marketCap":129422313900.82},{"date":"2021-07-16","current":9.010663,"twenty":9.638085,"median":21.140332,"eighty":27.848598,"marketCap":129770992211.6},{"date":"2021-07-23","current":9.031172,"twenty":9.62122,"median":21.117164,"eighty":27.80391,"marketCap":129576758627.22},{"date":"2021-07-30","current":18.87536,"twenty":9.610467,"median":21.085355,"eighty":27.796937,"marketCap":129351074870.7},{"date":"2021-08-06","current":18.73975,"twenty":9.613461,"median":21.013453,"eighty":27.749237,"marketCap":127349176618.04},{"date":"2021-08-13","current":19.000477,"twenty":9.62122,"median":20.964049,"eighty":27.709316,"marketCap":129532398703.09},{"date":"2021-08-20","current":19.713131,"twenty":9.626758,"median":20.922915,"eighty":27.702194,"marketCap":133040601577.1},{"date":"2021-08-27","current":19.159086,"twenty":9.631579,"median":20.849323,"eighty":27.682689,"marketCap":130505881690.84},{"date":"2021-09-03","current":19.087386,"twenty":9.636484,"median":20.812207,"eighty":27.640133,"marketCap":131037228600.12},{"date":"2021-09-10","current":17.788527,"twenty":9.637931,"median":20.810313,"eighty":27.621196,"marketCap":121557039339.96},{"date":"2021-09-17","current":17.718998,"twenty":9.644258,"median":20.781658,"eighty":27.597623,"marketCap":120158061709.12},{"date":"2021-09-24","current":17.821119,"twenty":9.653374,"median":20.756596,"eighty":27.571856,"marketCap":120553399377.05},{"date":"2021-10-01","current":17.949313,"twenty":9.657986,"median":20.686673,"eighty":27.533829,"marketCap":120210038226.29},{"date":"2021-10-08","current":18.316512,"twenty":9.65882,"median":20.60166,"eighty":27.49647,"marketCap":122456300914.25},{"date":"2021-10-15","current":18.21668,"twenty":9.659965,"median":20.367209,"eighty":27.481537,"marketCap":122085570969.84},{"date":"2021-10-22","current":18.492625,"twenty":9.660762,"median":19.534967,"eighty":27.418547,"marketCap":124266480579.27},{"date":"2021-10-29","current":17.57188,"twenty":9.660792,"median":19.400258,"eighty":27.363912,"marketCap":125449567069.84},{"date":"2021-11-05","current":17.984594,"twenty":9.662246,"median":19.19059,"eighty":27.343794,"marketCap":128307008370.7},{"date":"2021-11-12","current":18.139856,"twenty":9.664147,"median":19.148222,"eighty":27.315537,"marketCap":128214619445.91},{"date":"2021-11-19","current":18.074795,"twenty":9.669177,"median":19.129754,"eighty":27.3008,"marketCap":126337351612.14},{"date":"2021-11-26","current":17.283895,"twenty":9.672117,"median":19.062399,"eighty":27.290992,"marketCap":120754520924.52},{"date":"2021-12-03","current":17.031784,"twenty":9.672185,"median":18.974404,"eighty":27.274231,"marketCap":118697631154.76},{"date":"2021-12-10","current":17.593219,"twenty":9.673996,"median":18.883829,"eighty":27.261649,"marketCap":122887806332.16},{"date":"2021-12-17","current":17.666414,"twenty":9.676585,"median":18.822313,"eighty":27.226753,"marketCap":122981663791.86},{"date":"2021-12-23","current":17.924629,"twenty":9.677102,"median":18.797147,"eighty":27.187184,"marketCap":125231028798.23},{"date":"2021-12-31","current":18.010023,"twenty":9.680432,"median":18.68789,"eighty":27.152672,"marketCap":126457276638.23},{"date":"2022-01-07","current":18.01409,"twenty":9.687791,"median":18.583882,"eighty":27.099359,"marketCap":126127227506.24},{"date":"2022-01-14","current":18.425049,"twenty":9.694395,"median":18.458837,"eighty":27.042911,"marketCap":129932901404.91},{"date":"2022-01-21","current":18.490113,"twenty":9.694395,"median":18.493429,"eighty":27.028616,"marketCap":129474826588.41},{"date":"2022-01-28","current":19.165142,"twenty":9.694395,"median":18.494232,"eighty":27.028595,"marketCap":132074546389.11},{"date":"2022-02-04","current":18.213402,"twenty":9.69608,"median":18.572578,"eighty":27.025402,"marketCap":129696764676.74},{"date":"2022-02-11","current":18.927495,"twenty":9.697119,"median":18.616113,"eighty":27.010232,"marketCap":134335997389.37},{"date":"2022-02-18","current":18.766118,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":132345369395.97},{"date":"2022-02-25","current":18.833821,"twenty":9.697119,"median":18.575534,"eighty":27.010232,"marketCap":132044689275.57},{"date":"2022-03-04","current":17.617959,"twenty":9.697119,"median":18.491369,"eighty":27.010232,"marketCap":119664437682.82},{"date":"2022-03-11","current":18.783661,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127973204254.43},{"date":"2022-03-18","current":18.717451,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":128848117335.18},{"date":"2022-03-25","current":18.683343,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":127751282161.3},{"date":"2022-04-01","current":18.889374,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":129744565958.06},{"date":"2022-04-08","current":20.960102,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":141869390625.41},{"date":"2022-04-14","current":20.695242,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":139183497682.91},{"date":"2022-04-22","current":20.346108,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":136481434838.85},{"date":"2022-04-29","current":18.952765,"twenty":9.697119,"median":18.43883,"eighty":27.010232,"marketCap":133142723720.1},{"date":"2022-05-06","current":18.179144,"twenty":9.697119,"median":18.493429,"eighty":27.010232,"marketCap":128384549744.68},{"date":"2022-05-13","current":18.692394,"twenty":9.697119,"median":18.527753,"eighty":27.010232,"marketCap":129700736023.73},{"date":"2022-05-20","current":19.16256,"twenty":9.697119,"median":18.604323,"eighty":27.010232,"marketCap":134758546837.22},{"date":"2022-05-27","current":19.177546,"twenty":9.697119,"median":18.665261,"eighty":27.010232,"marketCap":136958987699.81},{"date":"2022-06-03","current":18.744225,"twenty":9.697119,"median":18.681313,"eighty":27.010232,"marketCap":133921762001.07},{"date":"2022-06-10","current":18.146643,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":127291929717.98},{"date":"2022-06-17","current":17.640852,"twenty":9.697119,"median":18.685349,"eighty":27.010232,"marketCap":123044805550.91},{"date":"2022-06-24","current":18.83789,"twenty":9.696859,"median":18.692394,"eighty":27.014025,"marketCap":132461365342.83},{"date":"2022-07-01","current":18.293193,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126838383992.09},{"date":"2022-07-08","current":18.63272,"twenty":9.696859,"median":18.693435,"eighty":27.014025,"marketCap":126418025181.68},{"date":"2022-07-15","current":18.795918,"twenty":9.696859,"median":18.717451,"eighty":27.014025,"marketCap":126431471445.01},{"date":"2022-07-22","current":18.263208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124455681540.58},{"date":"2022-07-29","current":18.321107,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":124140260314.16},{"date":"2022-08-05","current":18.377647,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123992191551.9},{"date":"2022-08-12","current":16.132936,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109885258896.75},{"date":"2022-08-19","current":15.415581,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102816971778.11},{"date":"2022-08-26","current":15.459,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102642813930.03},{"date":"2022-09-02","current":15.37405,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102457677511.04},{"date":"2022-09-09","current":15.328743,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102237792167.67},{"date":"2022-09-16","current":15.453336,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":102882856127.48},{"date":"2022-09-23","current":14.877565,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96093011237.72},{"date":"2022-09-30","current":14.800166,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":96408611153.17},{"date":"2022-10-07","current":15.132414,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":98274151179.98},{"date":"2022-10-14","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":99690906745.93},{"date":"2022-10-21","current":15.398591,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":100326441165.16},{"date":"2022-10-28","current":16.846401,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":107356651323.46},{"date":"2022-11-04","current":17.17473,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":109112652999.6},{"date":"2022-11-11","current":16.109615,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":106637600025.82},{"date":"2022-11-18","current":16.83559,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":111812739546.11},{"date":"2022-11-25","current":17.129097,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":114152420880.73},{"date":"2022-12-02","current":16.782758,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":112782528627.45},{"date":"2022-12-09","current":17.361946,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":117264953276.43},{"date":"2022-12-16","current":17.144751,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":116510134592.3},{"date":"2022-12-23","current":17.802208,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121183588329.26},{"date":"2022-12-30","current":17.579142,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":120406882967.83},{"date":"2023-01-06","current":17.829602,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":121279894677.35},{"date":"2023-01-13","current":17.841342,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":123710007946.55},{"date":"2023-01-20","current":17.659092,"twenty":9.696859,"median":18.719457,"eighty":27.014025,"marketCap":122645342505.42},{"date":"2023-01-27","current":17.429425,"twenty":9.703429,"median":18.719457,"eighty":27.014025,"marketCap":121260511615.28},{"date":"2023-02-03","current":12.687149,"twenty":9.709538,"median":18.719457,"eighty":27.014025,"marketCap":115251355422.68},{"date":"2023-02-10","current":13.217643,"twenty":9.726396,"median":18.719457,"eighty":27.014025,"marketCap":118159855219.99},{"date":"2023-02-17","current":13.277249,"twenty":9.741642,"median":18.719457,"eighty":27.014025,"marketCap":118515515804.01},{"date":"2023-02-24","current":13.411211,"twenty":9.752083,"median":18.719457,"eighty":27.014025,"marketCap":118448244308.93},{"date":"2023-03-03","current":13.302322,"twenty":9.756767,"median":18.719457,"eighty":27.014025,"marketCap":118034490740.94},{"date":"2023-03-10","current":13.357512,"twenty":9.764714,"median":18.719457,"eighty":27.014025,"marketCap":119257397037.12},{"date":"2023-03-17","current":13.394803,"twenty":9.773462,"median":18.719457,"eighty":27.014025,"marketCap":119526591543.55},{"date":"2023-03-24","current":14.48369,"twenty":9.785178,"median":18.719457,"eighty":27.014025,"marketCap":130424881067.13},{"date":"2023-03-31","current":14.952061,"twenty":9.790694,"median":18.718645,"eighty":27.010232,"marketCap":135988374469.8},{"date":"2023-04-06","current":15.280218,"twenty":9.798413,"median":18.718645,"eighty":27.010232,"marketCap":139686260171.45},{"date":"2023-04-14","current":15.221476,"twenty":9.80991,"median":18.730688,"eighty":27.025402,"marketCap":140825574178.82},{"date":"2023-04-19","current":15.209543,"twenty":9.82744,"median":18.731112,"eighty":27.026041,"marketCap":139558349488.11},{"date":"2023-04-27","current":15.21474,"twenty":9.850092,"median":18.73173,"eighty":27.027318,"marketCap":140140612943.9},{"date":"2023-05-05","current":15.175888,"twenty":9.902113,"median":18.731826,"eighty":27.028595,"marketCap":139552044885.56},{"date":"2023-05-12","current":14.838181,"twenty":9.939677,"median":18.731826,"eighty":27.028595,"marketCap":135403671391.13},{"date":"2023-05-19","current":15.184854,"twenty":9.959028,"median":18.731826,"eighty":27.028595,"marketCap":136642429723.27},{"date":"2023-05-26","current":14.853124,"twenty":9.978835,"median":18.733652,"eighty":27.028599,"marketCap":133126940240.24},{"date":"2023-06-02","current":14.192653,"twenty":10.040758,"median":18.733652,"eighty":27.028599,"marketCap":127343787455.44},{"date":"2023-06-09","current":14.256612,"twenty":10.09699,"median":18.733652,"eighty":27.028599,"marketCap":128372490395.43},{"date":"2023-06-16","current":14.295467,"twenty":10.208772,"median":18.72486,"eighty":27.028599,"marketCap":130508209942.1},{"date":"2023-06-23","current":14.734821,"twenty":10.181908,"median":18.697387,"eighty":27.028603,"marketCap":134961533039.24},{"date":"2023-06-30","current":14.675045,"twenty":10.181908,"median":18.683343,"eighty":27.028603,"marketCap":133521342889.49},{"date":"2023-07-07","current":14.039924,"twenty":10.181908,"median":18.651241,"eighty":27.028603,"marketCap":127451273212.04},{"date":"2023-07-14","current":14.002564,"twenty":10.181908,"median":18.628706,"eighty":27.028603,"marketCap":130982117535.26},{"date":"2023-07-21","current":14.736316,"twenty":10.181908,"median":18.609955,"eighty":27.028603,"marketCap":137261916493.54},{"date":"2023-07-28","current":14.230057,"twenty":10.155044,"median":18.575133,"eighty":27.028608,"marketCap":130696325708.32},{"date":"2023-08-04","current":13.64955,"twenty":10.155044,"median":18.53333,"eighty":27.028608,"marketCap":128783719369.32},{"date":"2023-08-11","current":14.107345,"twenty":10.155044,"median":18.465688,"eighty":27.028608,"marketCap":133909438393.92},{"date":"2023-08-18","current":14.257236,"twenty":10.155044,"median":18.417461,"eighty":27.028608,"marketCap":133639295738.06},{"date":"2023-08-25","current":14.360528,"twenty":10.155044,"median":18.371061,"eighty":27.028608,"marketCap":134024340566.45},{"date":"2023-09-01","current":14.34598,"twenty":10.155044,"median":18.34457,"eighty":27.028608,"marketCap":134077344689.8},{"date":"2023-09-08","current":14.597664,"twenty":10.155044,"median":18.325923,"eighty":27.028608,"marketCap":134604678073.84},{"date":"2023-09-15","current":14.95555,"twenty":10.155044,"median":18.296091,"eighty":27.016307,"marketCap":137463437822.93},{"date":"2023-09-22","current":14.853801,"twenty":10.12818,"median":18.276078,"eighty":27.020855,"marketCap":136484543397.31},{"date":"2023-09-29","current":14.763602,"twenty":10.12818,"median":18.246983,"eighty":26.983029,"marketCap":134423031209.85},{"date":"2023-10-06","current":14.868349,"twenty":10.12818,"median":18.218159,"eighty":26.938973,"marketCap":134892153493.37},{"date":"2023-10-13","current":15.040019,"twenty":10.12818,"median":18.16832,"eighty":26.598464,"marketCap":136737545848.28},{"date":"2023-10-20","current":14.380784,"twenty":10.12818,"median":18.144978,"eighty":26.402781,"marketCap":131062102932.84},{"date":"2023-10-27","current":11.85036,"twenty":10.092665,"median":18.111628,"eighty":26.025777,"marketCap":107534279335.51},{"date":"2023-11-03","current":11.80423,"twenty":10.092665,"median":18.07332,"eighty":25.817137,"marketCap":113606320100.85},{"date":"2023-11-10","current":11.775378,"twenty":10.092665,"median":18.059836,"eighty":25.817137,"marketCap":114360557197.64},{"date":"2023-11-17","current":11.879108,"twenty":10.092665,"median":18.023837,"eighty":25.817137,"marketCap":116984566837.93},{"date":"2023-11-24","current":11.946878,"twenty":10.092665,"median":18.009006,"eighty":25.817137,"marketCap":118113843833.15},{"date":"2023-12-01","current":11.863894,"twenty":10.092665,"median":17.972228,"eighty":25.817137,"marketCap":117306211282.58},{"date":"2023-12-08","current":11.912301,"twenty":10.09699,"median":17.952065,"eighty":25.812238,"marketCap":116514105188.26},{"date":"2023-12-15","current":12.129442,"twenty":10.09699,"median":17.934507,"eighty":25.812238,"marketCap":120907663627.27},{"date":"2023-12-22","current":12.356264,"twenty":10.09699,"median":17.886813,"eighty":25.812238,"marketCap":123141571763.22},{"date":"2023-12-29","current":12.414352,"twenty":10.092665,"median":17.852857,"eighty":25.817137,"marketCap":124666059594.59},{"date":"2024-01-05","current":12.928851,"twenty":10.088339,"median":17.827036,"eighty":25.822036,"marketCap":128452561703.01},{"date":"2024-01-12","current":13.228975,"twenty":10.088339,"median":17.806558,"eighty":25.822036,"marketCap":131304891825.05},{"date":"2024-01-19","current":13.006481,"twenty":10.084014,"median":17.776767,"eighty":25.826935,"marketCap":128114681751.41},{"date":"2024-01-26","current":12.735372,"twenty":10.088339,"median":17.745072,"eighty":25.822036,"marketCap":125131555256.31},{"date":"2024-02-02","current":20.334039,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":119118906599.05},{"date":"2024-02-09","current":20.085581,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116751493787.94},{"date":"2024-02-16","current":20.076293,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":116634730314.15},{"date":"2024-02-23","current":20.830953,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":121673497945.92},{"date":"2024-03-01","current":20.187328,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":117837605321.59},{"date":"2024-03-08","current":20.275189,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119656853104.92},{"date":"2024-03-15","current":20.393108,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":119946394721.71},{"date":"2024-03-22","current":20.497155,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":120191807946.57},{"date":"2024-03-28","current":21.03126,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122670991700.15},{"date":"2024-04-05","current":20.194264,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":118454296559.85},{"date":"2024-04-12","current":19.993107,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115628981743.6},{"date":"2024-04-19","current":20.090217,"twenty":10.088339,"median":17.71521,"eighty":25.822036,"marketCap":115682634323.95},{"date":"2024-04-26","current":25.102236,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":122028864510.98},{"date":"2024-05-03","current":25.121496,"twenty":10.092665,"median":17.717104,"eighty":25.817137,"marketCap":121965711156.52},{"date":"2024-05-10","current":25.955211,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":126909542740.01},{"date":"2024-05-17","current":24.564329,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121166222484.78},{"date":"2024-05-24","current":24.660746,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121128331641.95},{"date":"2024-05-31","current":24.726861,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":121676961247.02},{"date":"2024-06-07","current":25.104265,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":123964258787.81},{"date":"2024-06-14","current":23.809521,"twenty":10.092665,"median":17.717104,"eighty":25.881185,"marketCap":116305279179.76},{"date":"2024-06-21","current":24.137339,"twenty":10.088339,"median":17.71521,"eighty":25.90586,"marketCap":117375957434.63},{"date":"2024-06-28","current":24.776447,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":120367749389.79},{"date":"2024-07-05","current":25.051924,"twenty":10.079688,"median":17.696545,"eighty":25.961437,"marketCap":122903385527.57},{"date":"2024-07-12","current":26.005076,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":128286809560.82},{"date":"2024-07-15","current":25.462386,"twenty":10.079688,"median":17.696545,"eighty":25.984495,"marketCap":126116902211.31},{"date":"2024-08-02","current":28.58221,"twenty":10.045539,"median":17.667431,"eighty":25.970775,"marketCap":129963975586.71},{"date":"2024-08-09","current":28.611937,"twenty":10.045539,"median":17.667431,"eighty":26.395222,"marketCap":131603672136.16},{"date":"2024-08-16","current":29.365903,"twenty":10.045539,"median":17.667431,"eighty":26.965608,"marketCap":135991482271.53},{"date":"2024-08-23","current":29.827758,"twenty":10.045539,"median":17.667431,"eighty":27.30154,"marketCap":139679917173.16},{"date":"2024-08-30","current":30.083408,"twenty":10.045539,"median":17.667431,"eighty":27.737312,"marketCap":140486982478.95},{"date":"2024-09-06","current":31.076279,"twenty":10.045539,"median":17.667431,"eighty":27.755808,"marketCap":145252320920.18},{"date":"2024-09-13","current":30.737395,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":143002491189.58},{"date":"2024-09-20","current":30.78296,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144554419337.27},{"date":"2024-09-27","current":30.616469,"twenty":10.045539,"median":17.667431,"eighty":28.416222,"marketCap":144270741555.83},{"date":"2024-10-04","current":30.241865,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":140433638887.54},{"date":"2024-10-11","current":29.775602,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":137150593697.15},{"date":"2024-10-18","current":29.977793,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":136855848164.59},{"date":"2024-10-25","current":29.757762,"twenty":10.045539,"median":17.667431,"eighty":28.439522,"marketCap":135513851100.67},{"date":"2024-10-31","current":27.016329,"twenty":10.045539,"median":17.667431,"eighty":28.017403,"marketCap":132177608883.82},{"date":"2024-11-08","current":26.635368,"twenty":10.044628,"median":17.666414,"eighty":26.885017,"marketCap":129456333845.32},{"date":"2024-11-15","current":25.402919,"twenty":10.044628,"median":17.666414,"eighty":26.404422,"marketCap":121101937530.68},{"date":"2024-11-22","current":25.92038,"twenty":10.044628,"median":17.666414,"eighty":25.927346,"marketCap":122518864801.22},{"date":"2024-11-29","current":25.619919,"twenty":10.044628,"median":17.666414,"eighty":25.699083,"marketCap":121788536423.67},{"date":"2024-12-06","current":25.644957,"twenty":10.044628,"median":17.666414,"eighty":25.611269,"marketCap":122139495847.16},{"date":"2024-12-13","current":24.807559,"twenty":10.044628,"median":17.666414,"eighty":25.528111,"marketCap":117246552266.62},{"date":"2024-12-20","current":25.394572,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":118799775303.16},{"date":"2024-12-27","current":25.950983,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":121782054794.83},{"date":"2025-01-03","current":25.836919,"twenty":10.044628,"median":17.666414,"eighty":25.504351,"marketCap":119394068299.66},{"date":"2025-01-10","current":26.476134,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":122813940759.73},{"date":"2025-01-17","current":27.190583,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":126128028900.56},{"date":"2025-01-24","current":27.736112,"twenty":10.043718,"median":17.662753,"eighty":25.478661,"marketCap":130118603784.49},{"date":"2025-01-31","current":22.679241,"twenty":10.043718,"median":17.662753,"eighty":25.458421,"marketCap":135796476672.57},{"date":"2025-02-07","current":22.453317,"twenty":10.043718,"median":17.662753,"eighty":25.395685,"marketCap":133815994648.27},{"date":"2025-02-14","current":22.527177,"twenty":10.043718,"median":17.662753,"eighty":25.302609,"marketCap":135139535422.45},{"date":"2025-02-21","current":23.475533,"twenty":10.043718,"median":17.662753,"eighty":25.274251,"marketCap":136588490535.79},{"date":"2025-02-28","current":23.529645,"twenty":10.043718,"median":17.662753,"eighty":25.156716,"marketCap":136134051560.87},{"date":"2025-03-07","current":24.715596,"twenty":10.042807,"median":17.659092,"eighty":25.048936,"marketCap":148818188841.24},{"date":"2025-03-14","current":23.949012,"twenty":10.042807,"median":17.659092,"eighty":24.864048,"marketCap":144656712656.17},{"date":"2025-03-21","current":23.863334,"twenty":10.042807,"median":17.659092,"eighty":24.801725,"marketCap":143967164905.6},{"date":"2025-03-28","current":22.763528,"twenty":10.042807,"median":17.659092,"eighty":24.715596,"marketCap":136620485714.59},{"date":"2025-04-04","current":21.134417,"twenty":10.042807,"median":17.659092,"eighty":24.626125,"marketCap":130072347841.49},{"date":"2025-04-11","current":19.729859,"twenty":10.043718,"median":17.662753,"eighty":24.453364,"marketCap":122690991838.72},{"date":"2025-04-17","current":19.969823,"twenty":10.043718,"median":17.662753,"eighty":24.305248,"marketCap":126259056108.71},{"date":"2025-04-25","current":17.94759,"twenty":10.042807,"median":17.659092,"eighty":24.198495,"marketCap":128365926735.55},{"date":"2025-04-30","current":18.635491,"twenty":10.042807,"median":17.659092,"eighty":24.062008,"marketCap":133180117473.34}],"updateTime":1746128468367}}}